Clinical Trials Logo

Clinical Trial Summary

This is a single-blind, placebo-controlled, telemedicine clinical trial to assess the efficacy of cognitive behavioral therapy (CBT) in adult patients 18 years and older with familial dysautonomia (FD) and anxiety and/or depression and/or obsessive compulsive or related disorders. The trial will enroll 20 adult patients each with FD who have anxiety and/or depression and/or obsessive compulsive or related disorders by the DSM V criteria.

Enrolled participants will be allocated to receive, in a non-randomized fashion, weekly 5-10 min talking sessions (i.e., placebo) for 8 weeks, followed by weekly 30-60 min CBT sessions during 8 weeks. Although investigators will be un-blinded to the intervention, participants will be blinded to the expected effects of each intervention.

Both the talking sessions (i.e., placebo) and CBT sessions will be performed via telemedicine either via a HIPAA secure telemedicine platform or the telephone based on the preference of the individual patient. If a patient specifically requests talking or CBT sessions to be performed in person, this will be accommodated. The use of telemedicine is to accommodate disability and potential physical limitations of this unique patient population. The CBT sessions will be supervised by Lily Armstrong, certified mental health therapist and Dr. Thomas Boes, NYU Clinical Assistant Professor in the Departments of Psychiatric and Neurology.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03911063
Study type Interventional
Source NYU Langone Health
Contact
Status Withdrawn
Phase N/A
Start date April 1, 2019
Completion date April 1, 2021

See also
  Status Clinical Trial Phase
Withdrawn NCT02608931 - The Safety, Tolerability and Efficacy of Dronabinol, for the Treatment of Nausea and Vomiting in Familial Dysautonomia Phase 2
Completed NCT02276716 - The Nutritional Supplement Phosphatidylserine in Patients With Familial Dysautonomia Phase 2
Completed NCT02274051 - The Safety and Tolerability of Kinetin, in Patients With Familial Dysautonomia Phase 1
Completed NCT01987219 - The Effects Of Bronchodilator Therapy On Respiratory And Autonomic Function In Patients With Familial Dysautonomia Phase 3
Completed NCT01999257 - Efficacy Study of an Online Educational Module Before Carrier Genetic Screening in Persons of Ashkenazi Jewish Descent. N/A
Completed NCT03013777 - A Trial of Cognitive Behavioral Therapy in Familial Dysautonomia N/A
Completed NCT01212484 - Carbidopa for the Treatment of Nausea and Vomiting in Familial Dysautonomia Phase 3
Not yet recruiting NCT06148311 - Dexmedetomidine Sublingual Film for the Ambulatory Treatment of Hyperadrenergic Autonomic Crisis in Patients With Familial Dysautonomia Phase 2
Not yet recruiting NCT06128356 - Pilot Study of Dexmedetomidine Sublingual Film for the Ambulatory Treatment of Hyperadrenergic Autonomic Crisis in Patients With Familial Dysautonomia Phase 2